Skip to main content
Top
Published in: Annals of Surgical Oncology 13/2023

25-05-2023 | Hemicolectomy | ASO Author Reflections

ASO Author Reflections: Contemporary Management of Low-Grade Appendiceal Mucinous Neoplasms

Authors: Michael G. White, MD, MS, Christopher P. Scally, MD, MS

Published in: Annals of Surgical Oncology | Issue 13/2023

Login to get access

Excerpt

Low-grade appendiceal mucinous neoplasms (LAMN) represent a rare appendiceal tumor with a propensity for spread within the peritoneal cavity and the potential to develop a clinical presentation of pseudomyxoma peritonei but with otherwise very low metastatic potential. Although rare, these low-grade tumors are typically initially encountered outside of tertiary or quaternary referral centers. As such, there has been significant heterogeneity in the management of these tumors. White and colleagues recently described this heterogeneity in patients presenting to the MD Anderson Cancer Center for definitive care of their LAMN.1 Of note, a significant number of these patients received a right hemicolectomy without clear indication. Because these tumors rarely metastasize to the ileocolonic lymph nodes, both the American Society of Colon & Rectal Surgeons as well as the recent Chicago Consensus Guidelines do not recommend right hemicolectomy for oncologic staging.2,3 Rather, partial colectomy is recommended only in the setting of direct spread from the appendix to the cecum. An ileocectomy may therefore be required to obtain a clear margin. …
Literature
2.
go back to reference Chicago Consensus Working G. The Chicago consensus on peritoneal surface malignancies: management of appendiceal neoplasms. Ann Surg Oncol. 2020;27(6):1753–60.CrossRef Chicago Consensus Working G. The Chicago consensus on peritoneal surface malignancies: management of appendiceal neoplasms. Ann Surg Oncol. 2020;27(6):1753–60.CrossRef
3.
go back to reference Glasgow SC, Gaertner W, Stewart D, et al. The American society of colon and rectal surgeons, clinical practice guidelines for the management of appendiceal neoplasms. Dis Colon Rectum. 2019;62(12):1425–38.CrossRefPubMed Glasgow SC, Gaertner W, Stewart D, et al. The American society of colon and rectal surgeons, clinical practice guidelines for the management of appendiceal neoplasms. Dis Colon Rectum. 2019;62(12):1425–38.CrossRefPubMed
4.
go back to reference Shen JP, Yousef AM, Zeineddine FA, et al. A Prospective randomized crossover trial of systemic chemotherapy in patients with low-grade mucinous appendiceal adenocarcinoma. medRxiv. 2022:2022.2012.2006.22283164. Shen JP, Yousef AM, Zeineddine FA, et al. A Prospective randomized crossover trial of systemic chemotherapy in patients with low-grade mucinous appendiceal adenocarcinoma. medRxiv. 2022:2022.2012.2006.22283164.
5.
go back to reference Erali RA. Assessing the mucolytic and cytotoxic activity of bromelain in appendiceal cancer organoids. In: International conference on surgical cancer care; March 25, 2023, 2023; Boston, MA. Erali RA. Assessing the mucolytic and cytotoxic activity of bromelain in appendiceal cancer organoids. In: International conference on surgical cancer care; March 25, 2023, 2023; Boston, MA.
6.
go back to reference Vierra M, Dhiman A, Witmer HDD, et al. Celecoxib and Myrtol: a novel therapy for recurrent appendiceal mucinous neoplasms with extensive peritoneal dissemination. Am J Clin Oncol. 2022;45(1):9–13.CrossRefPubMed Vierra M, Dhiman A, Witmer HDD, et al. Celecoxib and Myrtol: a novel therapy for recurrent appendiceal mucinous neoplasms with extensive peritoneal dissemination. Am J Clin Oncol. 2022;45(1):9–13.CrossRefPubMed
Metadata
Title
ASO Author Reflections: Contemporary Management of Low-Grade Appendiceal Mucinous Neoplasms
Authors
Michael G. White, MD, MS
Christopher P. Scally, MD, MS
Publication date
25-05-2023
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 13/2023
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-023-13523-2

Other articles of this Issue 13/2023

Annals of Surgical Oncology 13/2023 Go to the issue